George A. Jacoby - Concepedia

Author

George A. Jacoby

Also Known As

G A Jacoby, G Jacoby, G. A. JACOBY, G. A. Jacoby, G.A. Jacoby, GEORGE A. JACOBY, GEORGE JACOBY, Gady Jacoby, George A Jacoby, George A. Jacoby

190

Publications

30.9K

Citations

H-Index

109

Concepts

All Affiliations

Massachusetts General Hospital Lahey Hospital and Medical Center Harvard University Lahey Medical Center Huashan Hospital

About

George A. Jacoby is an author at Massachusetts General Hospital specializing in medicine, microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	82	10.4K
2	Health Sciences	33	43	6.3K
3	Natural Sciences	8	8	1.5K
4	Engineering	5	5	240
5	Public Health	3	3	312

George A. Jacoby

118

Publications

14.1K

Citations

H-Index

Page 1

	Year	Citations
Quinolone resistance from a transferable plasmid Luis Martínez‐Martínez, Álvaro Pascual, George A. Jacoby The Lancet Antimicrobial Resistance GeneAntibioticsMedicineTransferable PlasmidMicrobiology	1998	1.1K
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Ari Robicsek, Jacob Strahilevitz, George A. Jacoby, Nature Medicine BiochemistryMedicineNatural SciencesEnzyme CatalysisChemical Biology	2005	1K
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme Chi Hye Park, Ari Robicsek, George A. Jacoby, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeEscherichia ColiAntibiotic ResistanceUnited StatesDrug Resistance	2006	739
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States Ari Robicsek, Jacob Strahilevitz, D.F. Sahm, Antimicrobial Agents and Chemotherapy Escherichia Coli IsolatesKlebsiella PneumoniaeAntibiotic ResistanceUnited StatesBacterial Pathogens	2006	570
Mechanism of plasmid-mediated quinolone resistance John H. Tran, George A. Jacoby Proceedings of the National Academy of Sciences	2002	570
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of <i>Escherichia coli</i> from Shanghai, China Minggui Wang, John H. Tran, George A. Jacoby, Antimicrobial Agents and Chemotherapy Plasmid-mediated Quinolone ResistanceKlebsiella PneumoniaeQuinolone ResistanceMolecular BiologyClinical Isolates	2003	466
<i>qnrB</i> , Another Plasmid-Mediated Gene for Quinolone Resistance George A. Jacoby, Kelley E. Walsh, Debra M. Mills, Antimicrobial Agents and Chemotherapy GeneticsKlebsiella PneumoniaeQuinolone ResistanceMolecular BiologyMolecular Genetics	2006	398
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility Louis B. Rice, Sandra Willey, Genovefa A. Papanicolaou, Antimicrobial Agents and Chemotherapy Ceftazidime ResistanceKlebsiella PneumoniaeAntibiotic ResistanceDrug ResistanceDifferent Strains	1990	382
Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period Hong Bin Kim, Chi Hye Park, Chung-Jong Kim, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeQuinolone ResistancePathologyEscherichia ColiAntibiotic Resistance	2008	331
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae Genovefa A. Papanicolaou, Antone A. Medeiros, George A. Jacoby Antimicrobial Agents and Chemotherapy Novel Plasmid-mediated Beta-lactamaseAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAlpha-methoxy Beta-lactams	1990	310

Page 1